News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,622 Results
Type
Article (44703)
Company Profile (311)
Press Release (688607)
Multimedia
Podcasts (110)
Webinars (16)
Section
Business (212554)
Career Advice (2188)
Deals (37145)
Drug Delivery (116)
Drug Development (84356)
Employer Resources (177)
FDA (16816)
Job Trends (15628)
News (360444)
Policy (34534)
Tag
Academia (2636)
Accelerated approval (12)
Adcomms (30)
Allergies (105)
Alliances (52220)
ALS (117)
Alzheimer's disease (1515)
Antibody-drug conjugate (ADC) (178)
Approvals (16800)
Artificial intelligence (342)
Autoimmune disease (35)
Automation (19)
Bankruptcy (378)
Best Places to Work (11854)
BIOSECURE Act (21)
Biosimilars (137)
Biotechnology (193)
Bladder cancer (97)
Brain cancer (38)
Breast cancer (386)
Cancer (3057)
Cardiovascular disease (239)
Career advice (1826)
Career pathing (33)
CAR-T (198)
CDC (36)
Cell therapy (530)
Cervical cancer (23)
Clinical research (69505)
Collaboration (1104)
Company closure (3)
Compensation (727)
Complete response letters (34)
COVID-19 (2728)
CRISPR (66)
C-suite (367)
Cystic fibrosis (118)
Data (3162)
Decentralized trials (2)
Denatured (33)
Depression (70)
Diabetes (365)
Diagnostics (6553)
Digital health (23)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (151)
Drug pricing (148)
Drug shortages (34)
Duchenne muscular dystrophy (152)
Earnings (89817)
Editorial (46)
Employer branding (21)
Employer resources (154)
Events (118040)
Executive appointments (887)
FDA (18600)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (976)
Gene editing (145)
Generative AI (28)
Gene therapy (420)
GLP-1 (888)
Government (4724)
Grass and pollen (6)
Guidances (200)
Healthcare (19178)
HIV (41)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (175)
Immuno-oncology (11)
Indications (42)
Infectious disease (2919)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (67)
Intellectual property (125)
Interviews (341)
IPO (17035)
IRA (54)
Job creations (4171)
Job search strategy (1557)
Kidney cancer (14)
Labor market (54)
Layoffs (547)
Leadership (25)
Legal (8555)
Liver cancer (80)
Longevity (12)
Lung cancer (427)
Lymphoma (220)
Machine learning (11)
Management (61)
Manufacturing (448)
MASH (100)
Medical device (13617)
Medtech (13623)
Mergers & acquisitions (20853)
Metabolic disorders (935)
Multiple sclerosis (104)
NASH (20)
Neurodegenerative disease (147)
Neuropsychiatric disorders (41)
Neuroscience (2261)
NextGen: Class of 2025 (6733)
Non-profit (4566)
Now hiring (49)
Obesity (481)
Opinion (264)
Ovarian cancer (103)
Pain (126)
Pancreatic cancer (129)
Parkinson's disease (196)
Partnered (22)
Patents (321)
Patient recruitment (179)
Peanut (54)
People (60289)
Pharmaceutical (98)
Pharmacy benefit managers (25)
Phase I (21653)
Phase II (30538)
Phase III (22863)
Pipeline (1743)
Policy (233)
Postmarket research (2687)
Preclinical (9173)
Press Release (68)
Prostate cancer (149)
Psychedelics (38)
Radiopharmaceuticals (263)
Rare diseases (510)
Real estate (6377)
Recruiting (68)
Regulatory (23989)
Reports (50)
Research institute (2401)
Resumes & cover letters (371)
Rett syndrome (9)
RNA editing (10)
RSV (59)
Schizophrenia (98)
Series A (164)
Series B (114)
Service/supplier (14)
Sickle cell disease (65)
Special edition (21)
Spinal muscular atrophy (154)
Sponsored (33)
Startups (3810)
State (2)
Stomach cancer (16)
Supply chain (84)
Tariffs (70)
The Weekly (75)
Vaccines (835)
Venture capital (57)
Weight loss (317)
Women's health (48)
Worklife (17)
Date
Today (128)
Last 7 days (498)
Last 30 days (1778)
Last 365 days (31890)
2025 (18231)
2024 (36163)
2023 (40938)
2022 (52120)
2021 (56675)
2020 (55111)
2019 (47831)
2018 (36142)
2017 (33573)
2016 (33172)
2015 (39015)
2014 (32966)
2013 (28086)
2012 (30170)
2011 (30873)
2010 (28890)
Location
Africa (814)
Alabama (64)
Alaska (7)
Arizona (253)
Arkansas (14)
Asia (42167)
Australia (6686)
California (7686)
Canada (2433)
China (719)
Colorado (327)
Connecticut (326)
Delaware (206)
Europe (90553)
Florida (1172)
Georgia (256)
Hawaii (2)
Idaho (60)
Illinois (672)
India (29)
Indiana (384)
Iowa (17)
Japan (244)
Kansas (110)
Kentucky (29)
Louisiana (15)
Maine (64)
Maryland (1066)
Massachusetts (5760)
Michigan (253)
Minnesota (468)
Mississippi (4)
Missouri (95)
Montana (28)
Nebraska (25)
Nevada (85)
New Hampshire (67)
New Jersey (2159)
New Mexico (31)
New York (2149)
North Carolina (1151)
North Dakota (8)
Northern California (3388)
Ohio (245)
Oklahoma (16)
Oregon (40)
Pennsylvania (1673)
Puerto Rico (18)
Rhode Island (37)
South America (1186)
South Carolina (35)
South Dakota (1)
Southern California (2880)
Tennessee (128)
Texas (1172)
United States (28664)
Utah (226)
Virginia (204)
Washington D.C. (73)
Washington State (656)
West Virginia (4)
Wisconsin (70)
733,622 Results for "evoke pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036
July 10, 2025
·
7 min read
Press Releases
Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
·
10 min read
Press Releases
Evoke Pharma to Present New Data Comparing Tardive Dyskinesia Incidence in Continuous vs Intermittent Metoclopramide Use at DDW 2025
April 28, 2025
·
7 min read
Press Releases
Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 14, 2025
·
15 min read
Press Releases
Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors
February 24, 2025
·
5 min read
Biotech Beach
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
Evoke Pharma, Inc., a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases with an emphasis on GIMOTI® nasal spray, announced updates regarding their business and commercial growth strategy.
June 17, 2024
·
9 min read
Business
Evoke Pharma Reports First Quarter 2024 Financial Results
Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced its financial results for the first quarter ended March 31, 2024, and recent corporate developments.
May 14, 2024
·
11 min read
Press Releases
Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
November 8, 2024
·
12 min read
Press Releases
Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025
March 6, 2025
·
3 min read
Biotech Beach
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis
Evoke Pharma, Inc. announced it will host a virtual KOL and investor webinar on Wednesday, April 24 at 12:00 p.m. ET.
April 17, 2024
·
5 min read
1 of 73,363
Next
